Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.
about
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus ChallengeActin-based motility of intracellular microbial pathogensCloak and Dagger: Alternative Immune Evasion and Modulation Strategies of PoxvirusesCoupling viruses to dynein and kinesin-1Vaccinia protein F12 has structural similarity to kinesin light chain and contains a motor binding motif required for virion exportVaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesinGeneration of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genesModulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.Repulsion of superinfecting virions: a mechanism for rapid virus spread.F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infectionRhoD Inhibits RhoC-ROCK-Dependent Cell Contraction via PAK6.Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesiclesVaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.Attenuation of vaccinia Tian Tan strain by removal of viral TC7L-TK2L and TA35R genes.Characterization of the vaccinia virus A35R protein and its role in virulence.Directed egress of animal viruses promotes cell-to-cell spreadMapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteinsDevelopment of ST-246® for Treatment of Poxvirus Infections.Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor.Vaccinia virus protein complex F12/E2 interacts with kinesin light chain isoform 2 to engage the kinesin-1 motor complexThe vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence.Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domainsSmallpox antiviral drug development: satisfying the animal efficacy rule.The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions.Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.The role of the cytoskeleton in the life cycle of viruses and intracellular bacteria: tracks, motors, and polymerization machines.Vaccinia virus WR53.5/F14.5 protein is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in miceVaccinia virus protein F12 associates with intracellular enveloped virions through an interaction with A36Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope.Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein.Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.An E2-F12 complex is required for intracellular enveloped virus morphogenesis during vaccinia infection.Vaccinia virus proteins A36 and F12/E2 show strong preferences for different kinesin light chain isoforms.Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.Divergent roles of β- and γ-actin isoforms during spread of vaccinia virus.Protein Primary Structure of the Vaccinia Virion at Increased ResolutionVaccinia virus utilizes microtubules for movement to the cell surface.Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis.
P2860
Q24535956-43EDF808-979E-44AE-8EAD-EB5D170FF5D6Q24548463-890A1DB4-521B-4249-AF45-0533F974487FQ26797325-2B2D5901-8CB5-45CC-BA25-875414AD3FA8Q26864993-52CB6562-5805-414E-BB17-E609F5ADBCF9Q27315837-281ADFCB-24E9-4864-BC90-AD6EC0570015Q28576187-9721D5DA-DEBB-4B93-AD2B-C3B219F027A5Q28659589-1F14F94C-C15A-49ED-A756-F8CCA6CE87CBQ30524111-42F66F28-1670-4924-8D26-A097A0D99665Q30594313-D92A1F58-720F-4398-8E8F-B51D7678D9CBQ33521248-BC7F8394-8E6C-49AD-9949-90072BD08924Q33658160-5C092A22-0D5D-4240-B72B-F84B0424881EQ33852860-3752E572-0802-476E-AE85-A22E4301BEC5Q33987410-14D5F423-53BB-4C1A-A60F-DE6E7E8C8C4EQ34171543-EF2F9F7B-AD85-4459-B284-3FF9C13CFCABQ34233032-F0DBCB93-891D-42B5-B328-B56A1473653BQ34327423-D76D42D4-525A-4AC2-9ABA-8D06F70A1F33Q34781856-1537BE96-6A83-4A94-86B9-4F715607F106Q35260385-4E412E53-2534-4711-9C8B-A1735673B258Q35512353-5D91E443-5969-47CF-AE70-2A934166CB3FQ35575087-1AEF746A-13B7-4135-B512-7F152F45AD5BQ35826480-56D0C881-DC15-4540-968E-8F4FFB01A2E2Q36171816-222F7CF2-4986-4868-8411-B28D33C63582Q36171927-E3BB4B67-5B8A-4A4F-B1F7-A1D9E5E4CDADQ36441506-3C38892A-FADC-4952-AD7E-271F6782A068Q36483943-AF3D32B1-1892-4AF0-8114-ECE886C322FCQ36540095-912F69AE-E50E-444C-BC6A-359E32788606Q36739620-827D6277-CC2F-41B4-A02B-77319AD1741EQ36933959-12AADCFE-7634-4C5F-8B81-39DFFF5C5FA5Q37099758-C70A7445-B1B9-4A28-ACF3-753D8939D8D9Q37395140-B2CB57FE-8C04-45F2-B1BC-49044B7EBA30Q38295116-F7F20E53-4391-4802-B408-7BF6EEEE4E7BQ38699683-E279D3C7-166C-47C7-9912-651D0247C7DBQ38711122-C521A4DA-3D4C-464E-B4C5-9C89910F1436Q39885253-86226981-FF5E-4CB5-AEB4-ACB61D3015A7Q40209222-49B809F4-A7CC-460C-9620-94A35672F375Q40243102-ED776624-D5E3-4122-81E2-57E422CFDE9FQ40325552-F80B233F-D956-4BE5-B4B9-C621A9E8427FQ40608542-A2772D2C-8D84-45A1-A01E-EC1B72DFF117Q40790144-EAEC45D6-0E16-4DC5-B3AE-E77D88BDC77DQ41933058-C9588409-F624-4DCB-8C72-21469F2D42AF
P2860
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Vaccinia virus F12L protein is ...... al plaque size, and virulence.
@ast
Vaccinia virus F12L protein is ...... al plaque size, and virulence.
@en
type
label
Vaccinia virus F12L protein is ...... al plaque size, and virulence.
@ast
Vaccinia virus F12L protein is ...... al plaque size, and virulence.
@en
prefLabel
Vaccinia virus F12L protein is ...... al plaque size, and virulence.
@ast
Vaccinia virus F12L protein is ...... al plaque size, and virulence.
@en
P2093
P2860
P1433
P1476
Vaccinia virus F12L protein is ...... al plaque size, and virulence.
@en
P2093
P2860
P304
11654-11662
P356
10.1128/JVI.74.24.11654-11662.2000
P577
2000-12-01T00:00:00Z